Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Transplant ; 24(4): 641-652, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37657654

RESUMO

Mollicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung transplantation; however, understanding of the epidemiology and outcomes of these infections remains limited. We conducted a single-center retrospective study of 1156 consecutive lung transplants performed from 2010-2019. We used log-binomial regression to identify risk factors for infection and analyzed clinical management and outcomes. In total, 27 (2.3%) recipients developed mollicute infection. Donor characteristics independently associated with recipient infection were age ≤40 years (prevalence rate ratio [PRR] 2.6, 95% CI 1.0-6.9), White race (PRR 3.1, 95% CI 1.1-8.8), and purulent secretions on donor bronchoscopy (PRR 2.3, 95% CI 1.1-5.0). Median time to diagnosis was 16 days posttransplant (IQR: 11-26 days). Mollicute-infected recipients were significantly more likely to require prolonged ventilatory support (66.7% vs 21.4%), undergo dialysis (44.4% vs 6.3%), and remain hospitalized ≥30 days (70.4% vs 27.4%) after transplant. One-year posttransplant mortality in mollicute-infected recipients was 12/27 (44%), compared to 148/1129 (13%) in those without infection (P <.0001). Hyperammonemia syndrome occurred in 5/27 (19%) mollicute-infected recipients, of whom 3 (60%) died within 10 weeks posttransplant. This study highlights the morbidity and mortality associated with mollicute infection after lung transplantation and the need for better screening and management protocols.


Assuntos
Transplante de Pulmão , Mycoplasma , Infecções por Ureaplasma , Humanos , Adulto , Estudos Retrospectivos , Infecções por Ureaplasma/epidemiologia , Infecções por Ureaplasma/etiologia , Infecções por Ureaplasma/diagnóstico , Transplante de Pulmão/efeitos adversos , Transplante de Pulmão/métodos , Fatores de Risco
2.
Case Rep Infect Dis ; 2020: 9623198, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32181030

RESUMO

Patients with systemic lupus erythematosus (SLE) are at increased risk for infection including opportunistic infections. Fungal infection in particular can be difficult to diagnose and treat and often can be life-threatening in the immunocompromised patient. We present a case in which a patient with SLE presented to the hospital with shortness of breath and cough. Throughout the hospital course, the patient's condition continued to decline leading to acute respiratory failure, and eventually, the patient expired. Postmortem autopsy revealed invasive fungal aspergillosis infection involving the heart, lungs, and brain. Earlier diagnosis and treatment with empiric antifungals may improve survival in these patients.

4.
J Natl Med Assoc ; 102(2): 132-4, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20191926

RESUMO

A 38-year-old female of African-Caribbean origin presented with symptomatic anemia and was found to have hypoplastic thumbs and patchy hypopigmentation. Peripheral blood examination revealed pancytopenia and the bone marrow biopsy confirmed marrow hypoplasia. Fanconi anemia was later confirmed by flow cytometry and diepoxybutane testing. Treatment was limited to transfusions after development of toxicity with cyclosporine and androgen therapy. She manifested classical features of transfusion-related hemosiderosis and died 12 years after initial presentation.


Assuntos
Anemia de Fanconi/diagnóstico , Adulto , Idade de Início , Transfusão de Sangue , Anemia de Fanconi/epidemiologia , Anemia de Fanconi/terapia , Feminino , Humanos , Quelantes de Ferro/uso terapêutico , Jamaica , Polegar/anormalidades
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...